Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TPMT | P51580 | 2/20 | 0.38 |
| ▸ | PREP | P48147 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3296656 | 0.96 | CA12 (0.41) | PLA2G2ACA12CA1CA9MEN1 | |
| SCHEMBL25665190 | 0.93 | RXRA (0.46) | CA12CA1CA9TPMTCA2 | |
| SCHEMBL7558013 | 0.92 | PLA2G2A (0.36) | PLA2G2ACA12CA1CA9MEN1 | |
| SCHEMBL6654531 | 0.89 | TPMT (0.48) | PLA2G2ACA12CA1CA9TPMT | |
| SCHEMBL6114920 | 0.85 | CA12 (0.41) | CA12CA1CA9MEN1KMT2A | |
| SCHEMBL29831305 | 0.84 | CA12 (0.40) | CA12CA1CA9PREP | |
| SCHEMBL18120875 | 0.83 | CA12 (0.38) | CA12CA1CA9PREP | |
| SCHEMBL2989104 | 0.83 | AKR1C3 (0.53) | CA12CA1CA9KMT2ARXRA | |
| SCHEMBL6625609 | 0.82 | KDM4E (0.44) | CA12CA1CA9PREPTSHR | |
| SCHEMBL7558007 | 0.82 | CA12 (0.39) | CA12CA1CA9PREP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113149930-B | Cell sugar transport channel inhibitor | 天津大学 | 2022-09-02 | — | — | CN | disclosed |
| CN-111808059-B | Tumor diagnosis and treatment fluorescent probe targeting tumor Woberg effect | 天津大学 | 2022-09-02 | — | — | CN | disclosed |
| US-10975307-B2 | Liquid crystalline epoxy compound with terminal mesogen connected by flexible linkage and method for preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2021-04-13 | — | — | US | disclosed |
| US-10975307-B2 | Liquid crystalline epoxy compound with terminal mesogen connected by flexible linkage and method for preparing the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2021-04-13 | — | — | US | disclosed |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20180201835-A1 | LIQUID CRYSTALLINE EPOXY COMPOUND WITH TERMINAL MESOGEN CONNECTED BY FLEXIBLE LINKAGE AND METHOD FOR PREPARING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-07-19 | — | — | US | disclosed |
| US-20180201835-A1 | LIQUID CRYSTALLINE EPOXY COMPOUND WITH TERMINAL MESOGEN CONNECTED BY FLEXIBLE LINKAGE AND METHOD FOR PREPARING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-07-19 | — | — | US | disclosed |
| US-20180201835-A1 | LIQUID CRYSTALLINE EPOXY COMPOUND WITH TERMINAL MESOGEN CONNECTED BY FLEXIBLE LINKAGE AND METHOD FOR PREPARING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-07-19 | — | — | US | disclosed |
| US-9896547-B2 | Polymerization method and polymers formed therewith | THE SCRIPPS RESEARCH INSTITUTE (US) | 2018-02-20 | — | — | US | disclosed |
| EP-2925803-B1 | POLYMERIZATION METHOD AND POLYMERS FORMED THEREWITH | SCRIPPS RESEARCH INST (US) | 2017-11-29 | — | — | EP | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-9447243-B2 | Polymerization method and polymers formed therewith | THE SCRIPPS RESEARCH INSTITUTE (US) | 2016-09-20 | — | — | US | disclosed |
| US-20150315340-A1 | POLYMERIZATION METHOD AND POLYMERS FORMED THEREWITH | THE SCRIPPS RESEARCH INSTITUTE | 2015-11-05 | — | — | US | disclosed |
| EP-2925803-A1 | POLYMERIZATION METHOD AND POLYMERS FORMED THEREWITH | The Scripps Research Institute (US) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014089078-A1 | POLYMERIZATION METHOD AND POLYMERS FORMED THEREWITH | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-06-12 | — | — | WO | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| EP-1124779-B1 | VITAMIN D ANALOGUES | GALDERMA RES & DEV (FR) | 2005-02-02 | — | — | EP | disclosed |
| US-6689922-B1 | BIAROMATIC COMPOUNDS WHICH ARE ANALOGUES OF VITAMIN D HAVE A MARKED ACTIVITY IN THE FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2004-02-10 | — | — | US | disclosed |
| EP-1124779-A1 | VITAMIN D ANALOGUES | Galderma Research & Development, S.N.C. (FR) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000026167-A1 | VITAMIN D ANALOGUES | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | PLA2G2A 2551/4885CA12 1571/4885CA1 2621/4885 |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | PLA2G2A 2551/4885CA12 1571/4885CA1 2621/4885 |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | PLA2G2A 2551/4885CA12 1571/4885CA1 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.